Zachary Kevin Sweeney

Person

Redwood City, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
LRRK2 inhibitors and methods of making and using thereof
- Patent number 12,358,896
- Issue date Jul 15, 2025
- Denali Therapeutics Inc.
- Javier de Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions and methods
- Patent number 12,358,928
- Issue date Jul 15, 2025
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions and methods
- Patent number 12,180,211
- Issue date Dec 31, 2024
- Denali Therapeutics Inc.
- Anthony A. Estrada
- G01 - MEASURING TESTING
Information Patent Grant
Compounds, compositions and methods
- Patent number 12,139,478
- Issue date Nov 12, 2024
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Kinase inhibitors and uses thereof
- Patent number 12,129,263
- Issue date Oct 29, 2024
- Denali Therapeutics Inc.
- Javier De Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of eukaryotic initiation factor 2B, compositions and met...
- Patent number 11,851,440
- Issue date Dec 26, 2023
- Denali Therapeutics Inc.
- Robert A. Craig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds, compositions and methods
- Patent number 11,851,433
- Issue date Dec 26, 2023
- Denali Therapeutics Inc.
- Giorgio Bonanomi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrimidines as LRKK2 inhibitors
- Patent number 11,840,529
- Issue date Dec 12, 2023
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions, and methods
- Patent number 11,834,439
- Issue date Dec 5, 2023
- Denali Therapeutics Inc.
- Javier de Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions, and methods
- Patent number 11,591,316
- Issue date Feb 28, 2023
- Denali Therapeutics Inc.
- Javier de Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of eukaryotic initiation factor 2B, compositions and met...
- Patent number 11,236,100
- Issue date Feb 1, 2022
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compound, compositions, and methods
- Patent number 11,214,565
- Issue date Jan 4, 2022
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Kinase inhibitors and uses thereof
- Patent number 11,203,600
- Issue date Dec 21, 2021
- Denali Therapeutics Inc.
- Javier De Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions and methods
- Patent number 11,174,262
- Issue date Nov 16, 2021
- Denali Therapeutics Inc.
- Giorgio Bonanomi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions, and methods
- Patent number 11,111,235
- Issue date Sep 7, 2021
- Denali Therapeutics Inc.
- Javier de Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions and methods
- Patent number 11,072,618
- Issue date Jul 27, 2021
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrimidines as LRKK2 inhibitors
- Patent number 11,028,080
- Issue date Jun 8, 2021
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of amphotericin B
- Patent number 10,882,883
- Issue date Jan 5, 2021
- Sfunga Therapeutics, Inc.
- Martin D. Burke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazolidine derived inhibitors of receptor interacting protein ki...
- Patent number 10,709,692
- Issue date Jul 14, 2020
- Denali Therapeutics Inc.
- Giorgio Bonanomi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds, compositions and methods
- Patent number 10,604,535
- Issue date Mar 31, 2020
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of amphotericin B
- Patent number 10,597,420
- Issue date Mar 24, 2020
- Sfunga Therapeutics, Inc.
- Martin D. Burke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions, and methods
- Patent number 10,590,114
- Issue date Mar 17, 2020
- Denali Therapautics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 10,407,445
- Issue date Sep 10, 2019
- Enanta Pharmaceuticals, Inc.
- Yao-Ling Qiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds, compositions and methods
- Patent number 10,131,676
- Issue date Nov 20, 2018
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline isoxazole hydroxamic acid compounds
- Patent number 10,071,973
- Issue date Sep 11, 2018
- Novartis AG
- Jiping Fu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole hydroxamic acid compounds as LpxC inhibitors
- Patent number 10,029,994
- Issue date Jul 24, 2018
- Novartis AG
- Jiping Fu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Derivatives of amphotericin B
- Patent number 9,957,290
- Issue date May 1, 2018
- Sfunga Therapeutics, Inc.
- Martin D. Burke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions, and methods
- Patent number 9,932,325
- Issue date Apr 3, 2018
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions and methods
- Patent number 9,896,458
- Issue date Feb 20, 2018
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2′-ethynyl nucleoside derivatives for treatment of viral infections
- Patent number 9,814,739
- Issue date Nov 14, 2017
- Novartis AG
- Sampath-Kumar Anandan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
LRRK2 INHIBITORS
- Publication number 20250066356
- Publication date Feb 27, 2025
- INTERLINE THERAPEUTICS, INC.
- Robert J. MOREAU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS, AND METHODS
- Publication number 20250034119
- Publication date Jan 30, 2025
- Denali Therapeutics Inc.
- Javier de Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Kinase Inhibitors and Uses Thereof
- Publication number 20250011338
- Publication date Jan 9, 2025
- Denali Therapeutics Inc.
- Javier De Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds, Compositions and Methods
- Publication number 20240150376
- Publication date May 9, 2024
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF EUKARYOTIC INITIATION FACTOR 2
- Publication number 20240140919
- Publication date May 2, 2024
- Denali Therapeutics Inc.
- Robert A. Craig II
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF EUKARYOTIC INITIATION FACTOR 2
- Publication number 20230250072
- Publication date Aug 10, 2023
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS, AND METHODS
- Publication number 20230227436
- Publication date Jul 20, 2023
- Denali Therapeutics Inc.
- Javier de Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds, Compositions and Methods
- Publication number 20230043400
- Publication date Feb 9, 2023
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modulators of eukaryotic initiation factor 2B, compositions and met...
- Publication number 20220411433
- Publication date Dec 29, 2022
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS, AND METHODS
- Publication number 20220220094
- Publication date Jul 14, 2022
- Denali Therapeutics Inc.
- Javier de Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20220177456
- Publication date Jun 9, 2022
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20220153728
- Publication date May 19, 2022
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS, AND METHODS
- Publication number 20220135546
- Publication date May 5, 2022
- Denali Therapeutics Inc.
- Javier de Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND, COMPOSITIONS, AND METHODS
- Publication number 20220119371
- Publication date Apr 21, 2022
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Kinase Inhibitors and Uses Thereof
- Publication number 20220041620
- Publication date Feb 10, 2022
- Denali Therapeutics Inc.
- Javier De Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds, Compositions and Methods
- Publication number 20220024938
- Publication date Jan 27, 2022
- Denali Therapeutics Inc.
- Giorgio Bonanomi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds, Compositions and Methods
- Publication number 20210332058
- Publication date Oct 28, 2021
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRIMIDINES AS LRKK2 INHIBITORS
- Publication number 20210300914
- Publication date Sep 30, 2021
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20210147435
- Publication date May 20, 2021
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRANSFERRIN RECEPTOR-BINDING POLYPEPTIDES AND USES THEREOF
- Publication number 20210130485
- Publication date May 6, 2021
- Denali Therapeutics Inc.
- Mark S. Dennis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF EUKARYOTIC INITIATION FACTOR 2
- Publication number 20210130308
- Publication date May 6, 2021
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS, AND METHODS
- Publication number 20210002260
- Publication date Jan 7, 2021
- Denali Therapeutics Inc.
- Javier de Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20200331900
- Publication date Oct 22, 2020
- Denali Therapeutics Inc.
- Robert A. Craig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds, Compositions and Methods
- Publication number 20200317691
- Publication date Oct 8, 2020
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DERIVATIVES OF AMPHOTERICIN B
- Publication number 20200262858
- Publication date Aug 20, 2020
- Sfunga Therapeutics, Inc.
- Martin D. Burke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20200157081
- Publication date May 21, 2020
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Kinase Inhibitors and Uses Thereof
- Publication number 20200087319
- Publication date Mar 19, 2020
- Denali Therapeutics Inc.
- Javier De Vicente Fidalgo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds, Compositions and Methods
- Publication number 20200079784
- Publication date Mar 12, 2020
- Denali Therapeutics Inc.
- Giorgio Bonanomi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds, Compositions and Methods
- Publication number 20190300537
- Publication date Oct 3, 2019
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS
- Publication number 20190112318
- Publication date Apr 18, 2019
- Denali Therapeutics Inc.
- Anthony A. Estrada
- C07 - ORGANIC CHEMISTRY

Zachary Kevin Sweeney

Person

Patents Grantslast 30 patents

LRRK2 inhibitors and methods of making and using thereof

Compounds, compositions and methods

Compounds, compositions and methods

Compounds, compositions and methods

Kinase inhibitors and uses thereof

Modulators of eukaryotic initiation factor 2B, compositions and met...

Compounds, compositions and methods

Substituted pyrimidines as LRKK2 inhibitors

Compounds, compositions, and methods

Compounds, compositions, and methods

Modulators of eukaryotic initiation factor 2B, compositions and met...

Compound, compositions, and methods

Kinase inhibitors and uses thereof

Compounds, compositions and methods

Compounds, compositions, and methods

Compounds, compositions and methods

Substituted pyrimidines as LRKK2 inhibitors

Derivatives of amphotericin B

Isoxazolidine derived inhibitors of receptor interacting protein ki...

Compounds, compositions and methods

Derivatives of amphotericin B

Compounds, compositions, and methods

Hepatitis C virus inhibitors

Compounds, compositions and methods

Crystalline isoxazole hydroxamic acid compounds

Isoxazole hydroxamic acid compounds as LpxC inhibitors

Derivatives of amphotericin B

Compounds, compositions, and methods

Compounds, compositions and methods

2′-ethynyl nucleoside derivatives for treatment of viral infections

Patents Applicationslast 30 patents

LRRK2 INHIBITORS

COMPOUNDS, COMPOSITIONS, AND METHODS

Kinase Inhibitors and Uses Thereof

Compounds, Compositions and Methods

MODULATORS OF EUKARYOTIC INITIATION FACTOR 2

MODULATORS OF EUKARYOTIC INITIATION FACTOR 2

COMPOUNDS, COMPOSITIONS, AND METHODS

Compounds, Compositions and Methods

Modulators of eukaryotic initiation factor 2B, compositions and met...

COMPOUNDS, COMPOSITIONS, AND METHODS

COMPOUNDS, COMPOSITIONS AND METHODS

COMPOUNDS, COMPOSITIONS AND METHODS

COMPOUNDS, COMPOSITIONS, AND METHODS

COMPOUND, COMPOSITIONS, AND METHODS

Kinase Inhibitors and Uses Thereof

Compounds, Compositions and Methods

Compounds, Compositions and Methods

SUBSTITUTED PYRIMIDINES AS LRKK2 INHIBITORS

COMPOUNDS, COMPOSITIONS AND METHODS

TRANSFERRIN RECEPTOR-BINDING POLYPEPTIDES AND USES THEREOF

MODULATORS OF EUKARYOTIC INITIATION FACTOR 2

COMPOUNDS, COMPOSITIONS, AND METHODS

COMPOUNDS, COMPOSITIONS AND METHODS

Compounds, Compositions and Methods

DERIVATIVES OF AMPHOTERICIN B

COMPOUNDS, COMPOSITIONS AND METHODS

Kinase Inhibitors and Uses Thereof

Compounds, Compositions and Methods

Compounds, Compositions and Methods

COMPOUNDS, COMPOSITIONS AND METHODS